US Stock MarketDetailed Quotes

OM Outset Medical

Watchlist
  • 1.210
  • +0.080+7.08%
Close Dec 26 16:00 ET
  • 1.200
  • -0.010-0.83%
Post 17:35 ET
63.58MMarket Cap-0.44P/E (TTM)

Outset Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-5.59%28.67M
-24.01%27.39M
-15.83%28.17M
13.00%130.38M
-4.69%30.51M
9.37%30.36M
43.83%36.04M
9.55%33.47M
12.45%115.38M
13.69%32.01M
Operating revenue
-5.59%28.67M
-24.01%27.39M
-15.83%28.17M
13.00%130.38M
-4.69%30.51M
9.37%30.36M
43.83%36.04M
9.55%33.47M
12.45%115.38M
13.69%32.01M
Cost of revenue
-18.78%18.85M
-37.87%17.61M
-26.21%19.95M
3.93%101.38M
-14.73%22.8M
-0.94%23.21M
33.19%28.34M
3.57%27.04M
2.68%97.54M
7.66%26.73M
Gross profit
37.21%9.82M
26.99%9.78M
27.80%8.22M
62.62%29M
46.25%7.71M
65.06%7.16M
103.68%7.7M
44.71%6.43M
134.40%17.83M
58.78%5.27M
Operating expense
-36.02%33.66M
-20.78%40.55M
-9.59%45.13M
11.14%198.77M
-0.07%45.07M
16.05%52.61M
7.74%51.18M
21.99%49.91M
29.48%178.85M
2.21%45.1M
Selling and administrative expenses
-30.15%25.52M
-15.06%30.81M
-10.04%32.49M
8.82%141.46M
-3.33%32.53M
13.20%36.54M
6.75%36.28M
20.06%36.12M
28.22%130M
2.88%33.65M
-Selling and marketing expense
-37.63%15.42M
-27.44%18.13M
-13.50%21.05M
7.54%96.23M
-6.08%22.19M
10.97%24.72M
7.70%24.99M
19.41%24.33M
37.52%89.48M
2.78%23.63M
-General and administrative expense
-14.49%10.1M
12.35%12.68M
-2.91%11.44M
11.64%45.23M
3.16%10.34M
18.15%11.82M
4.69%11.29M
21.40%11.79M
11.56%40.52M
3.12%10.02M
Research and development costs
-49.37%8.14M
-34.70%9.73M
-8.40%12.64M
17.30%57.31M
9.51%12.53M
23.10%16.08M
10.24%14.91M
27.35%13.79M
32.97%48.86M
0.30%11.44M
Operating profit
47.55%-23.84M
29.24%-30.76M
15.12%-36.91M
-5.43%-169.77M
6.20%-37.35M
-10.87%-45.45M
0.56%-43.48M
-19.22%-43.49M
-23.37%-161.02M
2.39%-39.82M
Net non-operating interest income expense
-512.34%-3.92M
-713.56%-3.54M
-876.19%-2.87M
-810.55%-2.5M
-500.53%-1.14M
-368.91%-640K
-1,877.27%-435K
2.65%-294K
77.40%-275K
38.64%-189K
Non-operating interest income
-16.48%2.15M
-7.38%2.47M
16.99%3.1M
209.05%10.17M
19.66%2.28M
219.63%2.57M
481.26%2.67M
2,106.67%2.65M
560.84%3.29M
1,450.41%1.91M
Non-operating interest expense
88.86%6.07M
93.68%6.01M
102.86%5.97M
255.44%12.68M
63.02%3.42M
466.67%3.21M
545.11%3.1M
597.16%2.94M
107.93%3.57M
386.31%2.1M
Other net income (expense)
-1.37M
Special income (charges)
----
----
----
--0
----
----
----
----
---1.37M
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--1.37M
----
Income before tax
39.78%-27.76M
21.88%-34.3M
9.13%-39.78M
-5.91%-172.27M
6.99%-38.49M
-13.08%-46.09M
-0.39%-43.91M
-19.04%-43.78M
-23.47%-162.66M
-0.66%-41.38M
Income tax
111.63%182K
13.53%151K
-15.63%162K
77.29%523K
75.00%112K
330.00%86K
38.54%133K
66.96%192K
48.24%295K
-48.80%64K
Net income
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-23.51%-162.96M
-0.51%-41.44M
Net income continuous Operations
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-23.51%-162.96M
-0.51%-41.44M
Minority interest income
Net income attributable to the parent company
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-23.51%-162.96M
-0.51%-41.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-23.51%-162.96M
-0.51%-41.44M
Basic earnings per share
40.86%-0.55
26.67%-0.66
13.33%-0.78
-2.96%-3.48
10.47%-0.77
-9.41%-0.93
2.17%-0.9
-15.38%-0.9
-16.96%-3.38
1.15%-0.86
Diluted earnings per share
40.86%-0.55
26.67%-0.66
13.33%-0.78
-2.96%-3.48
10.47%-0.77
-9.41%-0.93
2.17%-0.9
-15.38%-0.9
-16.96%-3.38
1.15%-0.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -5.59%28.67M-24.01%27.39M-15.83%28.17M13.00%130.38M-4.69%30.51M9.37%30.36M43.83%36.04M9.55%33.47M12.45%115.38M13.69%32.01M
Operating revenue -5.59%28.67M-24.01%27.39M-15.83%28.17M13.00%130.38M-4.69%30.51M9.37%30.36M43.83%36.04M9.55%33.47M12.45%115.38M13.69%32.01M
Cost of revenue -18.78%18.85M-37.87%17.61M-26.21%19.95M3.93%101.38M-14.73%22.8M-0.94%23.21M33.19%28.34M3.57%27.04M2.68%97.54M7.66%26.73M
Gross profit 37.21%9.82M26.99%9.78M27.80%8.22M62.62%29M46.25%7.71M65.06%7.16M103.68%7.7M44.71%6.43M134.40%17.83M58.78%5.27M
Operating expense -36.02%33.66M-20.78%40.55M-9.59%45.13M11.14%198.77M-0.07%45.07M16.05%52.61M7.74%51.18M21.99%49.91M29.48%178.85M2.21%45.1M
Selling and administrative expenses -30.15%25.52M-15.06%30.81M-10.04%32.49M8.82%141.46M-3.33%32.53M13.20%36.54M6.75%36.28M20.06%36.12M28.22%130M2.88%33.65M
-Selling and marketing expense -37.63%15.42M-27.44%18.13M-13.50%21.05M7.54%96.23M-6.08%22.19M10.97%24.72M7.70%24.99M19.41%24.33M37.52%89.48M2.78%23.63M
-General and administrative expense -14.49%10.1M12.35%12.68M-2.91%11.44M11.64%45.23M3.16%10.34M18.15%11.82M4.69%11.29M21.40%11.79M11.56%40.52M3.12%10.02M
Research and development costs -49.37%8.14M-34.70%9.73M-8.40%12.64M17.30%57.31M9.51%12.53M23.10%16.08M10.24%14.91M27.35%13.79M32.97%48.86M0.30%11.44M
Operating profit 47.55%-23.84M29.24%-30.76M15.12%-36.91M-5.43%-169.77M6.20%-37.35M-10.87%-45.45M0.56%-43.48M-19.22%-43.49M-23.37%-161.02M2.39%-39.82M
Net non-operating interest income expense -512.34%-3.92M-713.56%-3.54M-876.19%-2.87M-810.55%-2.5M-500.53%-1.14M-368.91%-640K-1,877.27%-435K2.65%-294K77.40%-275K38.64%-189K
Non-operating interest income -16.48%2.15M-7.38%2.47M16.99%3.1M209.05%10.17M19.66%2.28M219.63%2.57M481.26%2.67M2,106.67%2.65M560.84%3.29M1,450.41%1.91M
Non-operating interest expense 88.86%6.07M93.68%6.01M102.86%5.97M255.44%12.68M63.02%3.42M466.67%3.21M545.11%3.1M597.16%2.94M107.93%3.57M386.31%2.1M
Other net income (expense) -1.37M
Special income (charges) --------------0-------------------1.37M----
-Less:Other special charges ----------------------------------1.37M----
Income before tax 39.78%-27.76M21.88%-34.3M9.13%-39.78M-5.91%-172.27M6.99%-38.49M-13.08%-46.09M-0.39%-43.91M-19.04%-43.78M-23.47%-162.66M-0.66%-41.38M
Income tax 111.63%182K13.53%151K-15.63%162K77.29%523K75.00%112K330.00%86K38.54%133K66.96%192K48.24%295K-48.80%64K
Net income 39.50%-27.94M21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M-23.51%-162.96M-0.51%-41.44M
Net income continuous Operations 39.50%-27.94M21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M-23.51%-162.96M-0.51%-41.44M
Minority interest income
Net income attributable to the parent company 39.50%-27.94M21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M-23.51%-162.96M-0.51%-41.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.50%-27.94M21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M-23.51%-162.96M-0.51%-41.44M
Basic earnings per share 40.86%-0.5526.67%-0.6613.33%-0.78-2.96%-3.4810.47%-0.77-9.41%-0.932.17%-0.9-15.38%-0.9-16.96%-3.381.15%-0.86
Diluted earnings per share 40.86%-0.5526.67%-0.6613.33%-0.78-2.96%-3.4810.47%-0.77-9.41%-0.932.17%-0.9-15.38%-0.9-16.96%-3.381.15%-0.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
SilverCrest Metals
SILV
+2.40%
Cars.com
CARS
+2.25%
Lantheus
LNTH
+2.14%
Collegium Pharmaceutical
COLL
+1.48%
Hutchmed (China)
HCM
+1.19%

Unlock the Full List